Post All Antigens Are Not Created Equal | Unique Tumor Mutations Called Neoantigens Could Hold the Key to Personalized Cancer Therapies
Post CAR-T pioneer on riding the NIH roller coaster, speaking up for science, and his funder Sean Parker
Post The Parker Institute for Cancer Immunotherapy Appoints Immunotherapy Expert John Connolly as Chief Scientific Officer